| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| ANCA-associated vasculitis | 1 | 4 | |
| Cellulitis | 1 | 2 | |
| Pyoderma gangrenosum | 1 | 4 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 7 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| ANCA-associated vasculitis | 1 | 4 | |
| Cellulitis | 1 | 2 | |
| Pyoderma gangrenosum | 1 | 4 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 7 |